<DOC>
	<DOC>NCT00896987</DOC>
	<brief_summary>The purpose of this study is to compare the effect of anti-epileptic drugs' (AEDs) long-term treatment on cognitive function. This study is an open-label, randomized, multicenter comparative trial of lamotrigine versus carbamazepine. The planned enrollment is 100 patients.</brief_summary>
	<brief_title>Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Age : 16~60 Seizure type was defined by MRI etc. Had more than 2 unprovoked seizures or 1 seizure with clear evidence for epilepsy (ex. positive in EEG or brain imaging) Need AED therapy and no AED medication for previous 1 year (exclude emergency medication for less than 2 weeks, baseline 4 weeks before) Is not pregnant by pregnancy test and is using contraceptive method Can report seizure diary by him/herself or his/her sick nurse Agreed to trial by written consent Followup loss Canceled agreement Added other medication due to aggravated disease in 24 weeks Diagnosed as IGE Has progressive CNS disease by MRI or EEG Has serious systemic or psychological disease Under IQ 70 Baseline lad data abnormality: Creatinine 2.0mg/dl or GOT/GPT 2 times higher than normal Abuse experience on alcohol or drugs Has experience on serious adverse event of any drug Previous experience on lamotrigine or carbamazepine Not suitable patients by investigator (uncooperative) Other reason which may interrupt the trial</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>lamotrigine</keyword>
	<keyword>cognitive function</keyword>
</DOC>